Product Information

DICYCLOMINE 10 MG CAPSULE is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.0799 per EA under NDC 00054074825. Its NADAC has been published 171 times since Aug 9, 2023.

FDA first approved this application on Feb 28, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DICYCLOMINE 10 MG CAPSULE

Dicyclomine hydrochloride
$0.0799per EA

Strength

10 mg/1

NDC

00054074825

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

DICYCLOMINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA040204

FDA Approved

2/28/1997

TE Code

AB

On Market Since

2/28/1997

Pharmacological Classes

Anticholinergic
Cholinergic Antagonists

Price Statistics

The NADAC for DICYCLOMINE 10 MG CAPSULE has been published 171 times since Aug 9, 2023, and over the history we have for it it has declined 37.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0799 per EA
All-time high$0.1282 (Aug 16, 2023)
All-time low$0.0726 (Nov 20, 2024)
52-week high$0.0810
52-week low$0.0752
Median price$0.0822
Average price$0.0891
Largest weekly change+31.5% (Aug 21, 2024)
Weeks tracked171
Tracking sinceAug 9, 2023

Price History

1W

0.0%

1M

+2.8%

3M

+6.2%

6M

+5.1%

1Y

-1.7%

3Y

-30.0%

5Y

N/A

All

-37.7%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DICYCLOMINE 10 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for DICYCLOMINE 10 MG CAPSULE, manufactured by Hikma Pharmaceuticals USA Inc., is $0.0799 per EA (NDC 00054074825), effective Nov 11, 2026.

How has the price of DICYCLOMINE 10 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for DICYCLOMINE 10 MG CAPSULE has declined 37.7%. It has been tracked across 171 weekly CMS publications since Aug 9, 2023.

What are the highest and lowest recorded NADAC prices for DICYCLOMINE 10 MG CAPSULE?

Since Aug 9, 2023, the NADAC for DICYCLOMINE 10 MG CAPSULE has ranged from a low of $0.0726 (Nov 20, 2024) to a high of $0.1282 (Aug 16, 2023), with a median of $0.0822 per EA.

Are there cheaper alternatives to DICYCLOMINE 10 MG CAPSULE?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DICYCLOMINE 10 MG CAPSULE, is $0.0777 per EA — about 3% below DICYCLOMINE 10 MG CAPSULE.

Who manufactures DICYCLOMINE 10 MG CAPSULE?

DICYCLOMINE 10 MG CAPSULE (NDC 00054074825) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.